微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.56% | 109.27% | 9.8% | 35/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 0.51% | 114.13% | 15.91% | 33/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 0.44% | 148.35% | 102.2% | 30/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | -20.01% | -179.08% | -231.29% | 48/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | -6.04% | -829.23% | -67.31% | 48/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | -3.61% | -345.68% | -296.7% | 46/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | -0.91% | -89.58% | 87.31% | 41/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | -7.17% | -30.13% | -1003.08% | 41/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | -0.65% | -156.52% | 19.75% | 40/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | -0.81% | -163.78% | -68.75% | 40/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | -0.48% | -155.17% | 91.29% | 37/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | -5.51% | -217.23% | -579.13% | 41/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 1.15% | -82.55% | -9.45% | 29/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 1.27% | -66.31% | 45.98% | 33/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 0.87% | -67.78% | -81.49% | 22/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 4.7% | -65.94% | -28.68% | 35/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 6.59% | -56.96% | 74.8% | 19/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 3.77% | -50.39% | 39.63% | 21/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 2.7% | -67.27% | -80.43% | 6/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 13.8% | -4.7% | -9.86% | 22/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 15.31% | 7.36% | 101.45% | 8/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 7.6% | -13.83% | -7.88% | 9/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 8.25% | 97.37% | -43.02% | 2/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 14.48% | -18.79% | 1.54% | 17/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 14.26% | -3.58% | 61.68% | 6/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 8.82% | 193.33% | 111% | 7/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 4.18% | 42.18% | -76.56% | 2/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 17.83% | 361.05% | 20.55% | 7/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 14.79% | 348.99% | 256.51% | 4/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | -9.45% | -687.5% | -421.43% | 30/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 2.94% | 454.22% | 143.05% | 6/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | -6.83% | 35.14% | -14.98% | 31/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | -5.94% | 2.46% | -395% | 20/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | -1.2% | 65.52% | -44.58% | 22/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | -0.83% | 80.61% | 92.12% | 17/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | -10.53% | 36.64% | -72.91% | 29/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | -6.09% | 4.4% | -75% | 20/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | -3.48% | -1040.54% | 18.69% | 17/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | -4.28% | -239.68% | 74.25% | 17/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |